Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Small Cell Lung Carcinoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 231 Breast Neoplasms 131 Neoplasms 96 Prostatic Neoplasms 34 Fatigue 34 Obesity 24 Colorectal Neoplasms 22 Lung Neoplasms 20 Polycystic Ovary Syndrome 17 Ovarian Neoplasms 13 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Pancreatic Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Brain Neoplasms 8 Stomach Neoplasms 6 Peripheral Nervous System Diseases 6 Overweight 6 Cognitive Dysfunction 6 Cachexia 6

Interventions

Etoposide 150 Carboplatin 137 Cisplatin 99 Topotecan 74 durvalumab 48 atezolizumab 45 Irinotecan 44 pembrolizumab 38 Paclitaxel 34 Nivolumab 33 Radiotherapy 29 anlotinib 21 PM 01183 21 Gemcitabine 21 Drug Therapy 20 apatinib 19 Ipilimumab 18 Docetaxel 17 Temozolomide 16 Platinum 16 Radiosurgery 15 Pemetrexed 14 tislelizumab 13 olaparib 13 Bevacizumab 13 toripalimab 11 amrubicin 11 Magnetic Resonance Spectroscopy 11 Cyclophosphamide 11 rovalpituzumab tesirine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01881906 2018-09-06

EXHALE

Rigshospitalet, Denmark

Phase NA Completed

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡